The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Policy Notices

• Special Emphasis Notice (SEN): AHRQ Announces Interest in Research on Improving Organizational Health Literacy to Prevent and Manage Chronic Disease
  Agency for Healthcare Research and Quality

• Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations
  Agency for Healthcare Research and Quality

• Reminder: Changes to Forms and Instructions for Research Training Grant, Fellowship, and Career Development Award Applications for Applications Due on or After May 25, 2020
  National Institutes of Health
  Agency for Healthcare Research and Quality

General Notices

• Revised and Corrected Notice on Policy Regarding Minimum Level of Effort for NCI-Funded Awards
  National Cancer Institute

• Pre-Application Webinar for RFA-CA-20-027 and RFA-CA-20-028, Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01/R21 Clinical Trial Optional)
  National Cancer Institute

• Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19
  National Institute of General Medical Sciences

• Notice of NHGRI Interest in Receiving Letters Requesting Permission to Submit Applications to Support the NHGRI Research Training and Career Development Annual Meeting (U13)
  National Human Genome Research Institute

• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
  National Heart, Lung, and Blood Institute

• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-21-009, Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)
  National Heart, Lung, and Blood Institute

• NIH Plans to Migrate eRA Modules and Data to the Cloud April 17-20; All Systems Unavailable During Migration Window
  National Institutes of Health

• Notice of Information: Change in NCATS Prior Approval Process for New CTSA Program Pilot Projects that Involve Human Subjects Research
  National Center for Advancing Translational Sciences

Notice of Changes to Funding Opportunities

• Notice to Extend the Expiration Date for RFA-AG-21-016 "Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)"
  National Institute on Aging

• Notice to Extend the Expiration Date for PA-18-502 "Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional)"
  National Institute on Aging

• Notice to Extend the Expiration Date for PA-18-503 "Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional)"
  National Institute on Aging

• Notice of NIA Participation in PAR-20-157 "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)"
  National Institute on Aging

• Notice of Expiration of RFA-CA-19-046 "Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)
  National Cancer Institute

• Notice to Extend the Response Date for NOT-DK-20-015, Request for Information: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Strategic Plan
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)"
  National Institute of Environmental Health Sciences

• Notice of Early Expiration of NOT-ES-20-015, "Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
  National Institute of Environmental Health Sciences

• Notice of Change to the Application Due Date and correct Section II Award Information - Award Budget for RFA-FD-20-030 "Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01 Clinical Trials Optional"
  Food and Drug Administration

• Notice of An Additional Cycle of Receipt Dates Added to PAR-18-307 Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
  Office of Disease Prevention
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse

• Notice of An Additional Cycle of Receipt Dates Added to PAR-18-324 Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
  Office of Disease Prevention
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Minority Health and Health Disparities

• Notice of NCATS' Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  National Center for Advancing Translational Sciences

• Notice of NCATS Withdrawal from Participation in PAR-18-691, "Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional)
  National Center for Advancing Translational Sciences

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional)
  National Institute on Alcohol Abuse and Alcoholism

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Partnership between on Alcohol Research Centers and Institutions serving Underserved Communities and Populations (U54 Clinical Trial Optional)
  National Institute on Alcohol Abuse and Alcoholism

Requests for Proposal

• Pre-Solicitation Notice: Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents, RFP: 75N93019R00023
  National Institute of Allergy and Infectious Diseases

• Pre-Solicitation Notice: Immunology Quality Assessment (IQA) Program, RFP: 75N93020R00007
  National Institute of Allergy and Infectious Diseases

Notices of Special Interest

• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism

• Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)
  National Cancer Institute

• Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
  National Cancer Institute

• Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions
  National Cancer Institute

• Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases
  National Cancer Institute

• Notice of Special Interest (NOSI): Neuroimmune Signaling and Function in Substance Use Disorders
  National Institute on Drug Abuse

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)
  National Institute on Deafness and Other Communication Disorders

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
  National Institute of Biomedical Imaging and Bioengineering

• Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
  National Institute of Biomedical Imaging and Bioengineering

• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
  National Institute of Biomedical Imaging and Bioengineering

• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
  National Institute of Environmental Health Sciences

• NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)
  National Institute of Environmental Health Sciences

• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
  National Institute of Environmental Health Sciences

• Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19
  National Institute of General Medical Sciences

• Notice of Special Interest: Ancillary Reproductive Health Projects to Existing Large and/or Longitudinal Studies
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
  National Institute on Minority Health and Health Disparities
  National Institute on Aging
  National Institute of Mental Health

• Notice of Special Interest (NOSI): Supporting Research Education in High-Priority Intervention and Services Research Areas for Mentoring Networks for Mental Health Research Education and Short Courses for Mental Health Related Research
  National Institute of Mental Health

• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
  National Institute of Mental Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Minority Health and Health Disparities
  Office of Disease Prevention

• Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Promote Training in Clinical Research on Pain (Admin Supp Clinical Trial Not Allowed)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Special Interestregarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2
  National Institute of Neurological Disorders and Stroke

• Notice of Special Interest: Clinical and Translational Science Award (CTSA) Program Administrative Supplements
  National Center for Advancing Translational Sciences

• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
  National Center for Advancing Translational Sciences

• Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
  National Center for Advancing Translational Sciences

Funding Opportunities

• Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Clinical Trial Optional)
  National Institute on Alcohol Abuse and Alcoholism
   
• Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed)
  National Cancer Institute
   
• Reducing Stigma Related to Drug Use in Human Service Settings (R34 Clinical Trial Required)
  National Institute on Drug Abuse
  National Institute of Mental Health
   
• Reducing Stigma Related to Drug Use in Human Service Settings (R21 Clinical Trial Optional)
  National Institute on Drug Abuse
   
• CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed
  Food and Drug Administration
   
• Development of Fertility Regulation Methods by Small Business (R43/R44 Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
   
• Addressing Racial Disparities in Maternal Mortality and Morbidity (R01 Clinical Trial Optional)
  National Institute on Minority Health and Health Disparities
  National Heart, Lung, and Blood Institute
  National Institute of Nursing Research
  Office of the Director, NIH.
• NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
  National Institute of Mental Health

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu  or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu  or Dave Myers at dave-myers@uiowa.edu  or Lynn Hudachek at lynn-hudachek @uiowa.edu